Novavax Reports First Quarter 2024 Financial Results and Operational Highlights ...Middle East

PR Newswire - News
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights
Announces co-exclusive licensing agreement with Sanofi to co-commercialize COVID-19 vaccine, develop novel COVID-19-Influenza combination vaccines and develop multiple new vaccines utilizing Novavax's Matrix-MTM adjuvant This agreement represents a potential multi-billion dollar revenue...

Hence then, the article about novavax reports first quarter 2024 financial results and operational highlights was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Novavax Reports First Quarter 2024 Financial Results and Operational Highlights )

Apple Storegoogle play

Last updated :

Also on site :